Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Histone Modification02:32

Histone Modification

16.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
16.8K
Chromatin Immunoprecipitation- ChIP02:36

Chromatin Immunoprecipitation- ChIP

12.7K
Chromatin immunoprecipitation, or ChIP, is an antibody-based technique used to identify sites on DNA that bind to transcription factors of interest or histone proteins. It also helps determine the type of histone modifications such as acetylation, phosphorylation, or methylation.
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
12.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Striping artifact removal in VisiumHD data through nuclear counts modeling.

Bioinformatics (Oxford, England)·2026
Same author

UniversalEPI: robust prediction of cell type-specific and differential chromatin interactions from DNA sequence and chromatin accessibility.

Nucleic acids research·2026
Same author

A regulatory circuitry driving a noradrenergic to mesenchymal transition highlights YAP/TAZ as critical players in neuroblastoma plasticity.

Cell reports·2026
Same author

Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Robust and efficient annotation of cell states through gene signature scoring.

Genome research·2026
Same author

Early feature extraction drives model performance in high-resolution chromatin accessibility prediction.

Genome research·2026

Related Experiment Video

Updated: Mar 9, 2026

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF
05:52

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF

Published on: January 12, 2024

1.7K

HMCan-diff: a method to detect changes in histone modifications in cells with different genetic characteristics.

Haitham Ashoor1, Caroline Louis-Brennetot2, Isabelle Janoueix-Lerosey2

  • 1King Abdullah University of Science and Technology (KAUST), Computational Bioscience Research Center (CBRC), Computer, Electrical and Mathematical Sciences and Engineering Division (CEMSE), Thuwal 23955-6900, Saudi Arabia.

Nucleic Acids Research
|January 6, 2017
PubMed
Summary

HMCan-diff is a new tool that analyzes ChIP-seq data to accurately detect histone modification changes in cancer. It corrects for copy number variations, improving cancer research and therapy insights.

More Related Videos

The ChroP Approach Combines ChIP and Mass Spectrometry to Dissect Locus-specific Proteomic Landscapes of Chromatin
24:02

The ChroP Approach Combines ChIP and Mass Spectrometry to Dissect Locus-specific Proteomic Landscapes of Chromatin

Published on: April 11, 2014

18.8K
Author Spotlight: Enhancements in Gene Expression Regulation Research
07:10

Author Spotlight: Enhancements in Gene Expression Regulation Research

Published on: September 15, 2023

2.7K

Related Experiment Videos

Last Updated: Mar 9, 2026

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF
05:52

Author Spotlight: Enhanced Histone PTM Isomer Identification Through LC-TIMS-ToF MS/MS and PASEF

Published on: January 12, 2024

1.7K
The ChroP Approach Combines ChIP and Mass Spectrometry to Dissect Locus-specific Proteomic Landscapes of Chromatin
24:02

The ChroP Approach Combines ChIP and Mass Spectrometry to Dissect Locus-specific Proteomic Landscapes of Chromatin

Published on: April 11, 2014

18.8K
Author Spotlight: Enhancements in Gene Expression Regulation Research
07:10

Author Spotlight: Enhancements in Gene Expression Regulation Research

Published on: September 15, 2023

2.7K

Area of Science:

  • Genomics
  • Cancer Biology
  • Epigenetics

Background:

  • Histone modification profiles offer insights into cancer initiation, progression, and therapy response.
  • ChIP-seq data in cancer is often distorted by inherent copy number variations.
  • Accurate analysis of histone modifications is crucial for understanding cancer heterogeneity.

Purpose of the Study:

  • To introduce HMCan-diff, a novel method for analyzing ChIP-seq data to detect histone modification changes.
  • To explicitly correct for copy number bias and other biases in cancer ChIP-seq data.
  • To improve the accuracy of detecting histone modification differences between cancer and normal samples or across different cancer types.

Main Methods:

  • Developed HMCan-diff, a computational method specifically designed for ChIP-seq data analysis in cancer.
  • Implemented explicit corrections for copy number variation and other biases within ChIP-seq data.
  • Validated HMCan-diff using in silico simulated data and four experimental datasets.

Main Results:

  • HMCan-diff demonstrated significantly improved prediction accuracy compared to methods without copy number correction.
  • Simulated data analysis showed superior performance of HMCan-diff against non-correcting methods.
  • Benchmarking on experimental datasets confirmed HMCan-diff's enhanced performance in characterizing histone marks and correlating them with gene expression.

Conclusions:

  • HMCan-diff is the first method to effectively correct for copy number bias in cancer ChIP-seq data.
  • The method enhances the accuracy of detecting histone modification changes, aiding cancer research.
  • HMCan-diff provides a more reliable approach for analyzing epigenetic alterations in cancer studies and therapeutic development.